title: The pharmacology of antiulcer drugs.
abstract: The use of medications for the treatment of gastrointestinal ulcers has evolved to a great extent since the early days of therapy with diet and antacids. Today a number of different agents are available to treat the causative factors of ulcer formation. Currently, antacids, histamine2-receptor antagonists, and sucralfate are considered frontline therapies suitable for most patients. The future also looks promising for newer agents, such as omeprazole and prostaglandin analogs. The purpose of this article is to provide practitioners with an understanding of the achieved more efficiently and effectively.
authors.affiliation: Division of Clinical Pharmacology, University of Kansas Medical Center, Kansas City.
authors.forename: A
authors.initials: A
authors.lastname: Hurwitz
authors.forename: C A
authors.initials: CA
authors.lastname: Carter
mesh_terms: D000897:Anti-Ulcer Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000897:Anti-Ulcer Agents